Table 1 Characteristics of T4 NPC patients with intracranial extension who were treated with IMRT plus chemotherapy
Characteristic | No. of patients (%) |
|---|---|
Age (years) | |
Median (range) | 46 (21–65) |
Gender | |
Male | 33 (80.5) |
Female | 8 (19.5) |
Histology | |
WHO type II | 1 (2.4) |
WHO type III | 40 (97.6) |
KPS | |
70 | 5 (12.2) |
80 | 27 (65.8) |
90 | 9 (22.0) |
N category | |
N0 | 2 (4.9) |
N1 | 23 (56.1) |
N2 | 11 (26.8) |
N3 | 5 (12.2) |
Stage | |
IVA | 36 (87.8) |
IVB | 5 (12.2) |
Completion of chemotherapy | |
Induction (2 cycles) | 41 (100) |
Adjuvant (2 cycles) | 26 (63.4) |
Adjuvant (1 cycle) | 7 (17.1) |
Adjuvant (0 cycles) | 8 (19.5) |